Neil Warma - Oct 8, 2024 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Executive Officer
Signature
/s/ Max A. Milbury, Attorney in Fact for Neil Warma
Stock symbol
PMN
Transactions as of
Oct 8, 2024
Transactions value $
$0
Form type
4
Date filed
10/10/2024, 05:03 PM
Previous filing
Jan 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Option (right to buy) Award $0 +1.14M +549.18% $0.00 1.35M Oct 8, 2024 Common Shares 1.14M $1.15 Direct F1
transaction PMN Option (right to buy) Award $0 +490K +36.26% $0.00 1.84M Oct 8, 2024 Common Shares 490K $1.15 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Initial Award is 25% vested upon grant with the remaining shares vesting ratably over thirty-six months
F2 Performance Award shall vest 25% on the date that the 10-day VWAP of the Common Shares on the Nasdaq Capital Market exceeds three times the exercise price, $3.45, with the remainder vesting ratably over the following thirty-six months